INFI Key Stats
- Nasdaq stocks posting largest percentage decreases Yahoo 03/05 18:03 ET
- Infinity Pharmaceutical (INFI) 'Overvalued'; Wedbush Starts at Underperform Street Insider 03/03 16:50 ET
- Infinity to Present at the Upcoming Bernstein Emerging Biotech Conference noodls 03/03 08:18 ET
- INFINITY PHARMACEUTICALS, INC. Financials Yahoo 02/28 13:04 ET
- Infinity Pharma Rises on Narrower-than-Expected Loss Yahoo 02/26 10:20 ET
- Infinity Pharmaceuticals (INFI) Jumps: Stock Adds 15.5% in Session Yahoo 02/26 06:30 ET
- Infinity Pharma Rises on Narrower-than-Expected Loss - Analyst Blog Zacks 02/26 05:20 ET
- Infinity Pharmaceuticals (INFI) Jumps: Stock Adds 15.5% in Session - Tale of the Tape Zacks 02/26 02:51 ET
- Why Infinity Pharmaceuticals Inc. Shares Jumped Yahoo 02/25 13:19 ET
- Infinity Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript Seeking Alpha 02/25 12:05 ET
INFI Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Infinity Pharmaceuticals is down 69.39% over the last year vs S&P 500 Total Return up 24.21%, Actelion up 102.5%, and Aratana Therapeutics up N/A.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for INFI
Pro Report PDF for INFI
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download INFI Pro Report PDF
Pro Strategies Featuring INFI
Did Infinity Pharmaceuticals make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Headquarters Country: United States
- Headquarters State/Province: Massachusetts
- Incorporation Country: United States
- Incorporation State/Province: Delaware
Infinity Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering, developing & delivering medicines to people with difficult-to-treat diseases. Its primary product candidate is IPI-145, an oral inhibitor of phosphoinositide-3-kinase.